Caption Management, LLC Omeros Corp Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$13.4 - $16.3 $1.56 Million - $1.9 Million	-116,517 Reduced 52.35%	106,054 $1.46 Million
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $544,326 - $703,104	36,754 Added 19.78%	222,571 $3.3 Million
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $1.17 Million - $1.89 Million	80,349 Added 76.18%	185,817 $3.31 Million
Q4 2020 Feb 16, 2021	BUY	$10.14 - $15.19 $91,797 - $137,515	9,053 Added 9.39%	105,468 $1.51 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $922,691 - $2.06 Million	96,415 New	96,415 $973,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.